Acorn Biolabs announces $11-million CAD Series A to boost access to regenerative medicine via cell preservation
Biotech startup aims to unlock hair regrowth, skin rejuvenation, disease treatment by preserving cells.
Biotech startup aims to unlock hair regrowth, skin rejuvenation, disease treatment by preserving cells.
After finding product-market fit, Ginger Desk aims to build the platform it needs to scale.
Plus: Once worth $2.3B, COVID-19 test maker Cue Health shutters.
IDEATE is being supported by a $2.1-million investment from PrairiesCan.
The startup is looking to expand across Canada and the United States starting later this year.
Clarius’ handheld device will be used to support the early detection of psoriatic arthritis.
Amplitude has already made four investments from Fund II.
Down rounds rose from seven percent in 2022 to 31 percent last year.
Two dozen third-party science and research organizations are being backed by the new Strategic Science Fund.
Projects from Swift Medical, RxPx, Gotcare, and AlayaCare carry a collective $26-million value.
Plus: CloudMD to go private after acquisition spree dries liquidity.
“Federally procured and provincially distributed” healthcare alienates practitioners from process.
Bronwyn Bridges discusses her journey into healthtech with PragmaClin and her entrepreneurial “superpower.”
Pre-seed, seed-stage VC funding declines as late-stage investment continues descent.
Plus: Oracle’s $28-billion Cerner healthtech acquisition is losing clients.